Dec 20, 2022 8:00am EST MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
Nov 15, 2022 8:00am EST MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma
Nov 09, 2022 4:15pm EST MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Sep 29, 2022 9:01am EDT MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Sep 08, 2022 8:00am EDT MAIA Biotechnology to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Sep 06, 2022 8:00am EDT MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022
